Cardura Xl

— THERAPEUTIC CATEGORIES —
  • Benign prostatic hyperplasia/urinary retention

Cardura Xl Generic Name & Formulations

General Description

Doxazosin (as mesylate) 4mg, 8mg; ext-rel tabs.

Pharmacological Class

Alpha-1 blocker.

How Supplied

Tabs—30

Manufacturer

Cardura Xl Indications

Indications

BPH.

Cardura Xl Dosage and Administration

Adult

Swallow whole. Take w. breakfast. Initially 4mg once daily; may titrate after 3–4 weeks to max 8mg/day. If therapy is stopped for several days, restart at 4mg once daily. Switching from Cardura to Cardura XL: initially 4mg once daily; do not take final evening dose of Cardura. Concomitant PDE-5 inhibitors: initiate at lowest dose.

Children

Not established.

Cardura Xl Contraindications

Not Applicable

Cardura Xl Boxed Warnings

Not Applicable

Cardura Xl Warnings/Precautions

Warnings/Precautions

Severe hepatic impairment: not recommended. Mild or moderate hepatic impairment. Syncope. Symptomatic hypotension. Exclude prostate cancer. Severe GI narrowing. Coronary insufficiency; discontinue if angina pectoris appears or worsen. Cataract surgery (intraoperative floppy iris syndrome possible). Elderly. Pregnancy, nursing mothers: not indicated for females.

Cardura Xl Pharmacokinetics

See Literature

Cardura Xl Interactions

Interactions

Caution with strong CYP3A4 inhibitors (eg, atanazavir, clarithromycin, indinavir, ketoconazole, itraconazole, nefazodone, others). Additive hypotension with concomitant PDE-5 inhibitors.

Cardura Xl Adverse Reactions

Adverse Reactions

Headache, dizziness, asthenia, hypotension, dyspnea, postural hypotension, somnolence, respiratory or urinary tract infections; rare: priapism.

Cardura Xl Clinical Trials

See Literature

Cardura Xl Note

Not Applicable

Cardura Xl Patient Counseling

See Literature